Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dycom Industries, Inc. Common Stock (NY:DY)

284.33 -5.35 (-1.85%)
Official Closing Price Updated: 4:10 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dycom Industries, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023
 
Via Benzinga
Preview: Dycom Industries's Earnings
 
Via Benzinga
4 Analysts Have This to Say About Dycom Industries
 
Via Benzinga
Dycom Industries Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Dycom Industries, Inc. to Present at the D.A. Davidson 22nd Annual Diversified Industrials & Services Conference
From Dycom Industries Inc
Via GlobeNewswire
Stocks Like Rising Yields, Wait What?
Stakes couldn’t be higher for NVIDIA. Earnings expected to hit $2.07 (up +305% from $0.51 last year). It’s been the best performing stock in the S&P 500 this year, up +212%. If they miss the entire... 
Via Benzinga
Dycom Amplifies Rural Broadband Service Via Bigham Deal; Plans New $150M Stock Buyback
Dycom Industries Inc (NYSE: DY) has acquired Bigham Cable Construction, Inc.  
Via Benzinga
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Dycom Industries Shares Are Gaining Today
 
Via Benzinga
Dycom Industries: Q1 Earnings Insights
 
Via Benzinga
Earnings Outlook For Dycom Industries
 
Via Benzinga
Earnings Scheduled For August 23, 2023
Companies Reporting Before The Bell • ATRenew (NYSE:RERE) is estimated to report quarterly earnings at $0.06 per share on revenue of $397.98 million. 
Via Benzinga
Dycom Announces Authorization of a New $150 Million Stock Repurchase Program
From Dycom Industries Inc
Via GlobeNewswire
The Latest Analyst Ratings for Dycom Industries
 
Via Benzinga
Dycom Announces Acquisition of Bigham Cable Construction, Inc.
From Dycom Industries Inc
Via GlobeNewswire
Dycom Industries, Inc. Announces Fiscal 2024 Second Quarter Results
From Dycom Industries Inc
Via GlobeNewswire
Dycom Industries, Inc. to Host Fiscal 2024 Second Quarter Results Conference Call
From Dycom Industries Inc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
 
Via Benzinga
Dycom Industries, Inc. Appoints Luis Avila-Marco As Director
From Dycom Industries Inc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023
 
Via Benzinga
Dycom Industries, Inc. to Participate in Upcoming Investor Conferences
From Dycom Industries Inc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
 
Via Benzinga
US Futures Jump Led By Record-Breaking Surge In Nvidia
US equity futures are higher led by tech names after blowout earnings reported by Nvidia - which as Goldman reminds us 
Via Talk Markets
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For May 24, 2023
Companies Reporting Before The Bell • Bank of Nova Scotia (NYSE:BNS) is estimated to report quarterly earnings at $1.78 per share on revenue of $8.09 billion. 
Via Benzinga
Dycom Industries, Inc. Announces Fiscal 2024 First Quarter Results
From Dycom Industries Inc
Via GlobeNewswire
Dycom Industries, Inc. to Host Fiscal 2024 First Quarter Results Conference Call
From Dycom Industries Inc
Via GlobeNewswire
4 Stocks To Watch From The Prosperous Heavy Construction Industry
Unprecedented supply-chain issues, a tight labor market, as well as rising costs, are all taking a toll on the heavy construction industry. Despite this, these four companies in the space have been... 
Via Talk Markets
Dycom Industries, Inc. To Participate in Upcoming Investor Conferences
From Dycom Industries Inc
Via GlobeNewswire
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.